Article
Licensed
Unlicensed
Requires Authentication
Legal Framework Surrounding the Development of Vaccines for Select Agents: Do the Legal Incentives Outweigh the Legal Burdens?
-
Joel F. Aldrich
Published/Copyright:
November 24, 2015
Abstract
The United States Government has sought to incentivize the development of medical countermeasures for biological agents (as well as other weapons of mass destruction) by establishing the Biomedical Advanced Research and Development Authority (BARDA). Several legal impediments exist to the development of vaccines targeting the most disconcerting biological agents. This paper identifies the key legal incentives and impediments regarding the development of vaccines for select agents and determine whether these incentives currently outweigh the impediments.
Published Online: 2015-11-24
Published in Print: 2015-12-1
©2015 by De Gruyter
You are currently not able to access this content.
You are currently not able to access this content.
Articles in the same Issue
- Frontmatter
- Articles
- The BWC Gray Area: Locating the Blurry Line of Defining Biological Weapons
- Eco-Terrorism: A Legal Update on the Laws Protecting Scientific Research from Extremist Activists
- Legal Framework Surrounding the Development of Vaccines for Select Agents: Do the Legal Incentives Outweigh the Legal Burdens?
- Preparing for Agroterror: How is the Texas Animal Health Commission Implementing Federal Food Security Regulations?
- No Safe Haven: How the Chasm between the Laws Governing Refugees and Mass Gatherings Has Contributed to Health Crises
- Lost at Sea – Plunge into Cruise Ship Jurisdiction: Which Governmental Agency Regulates Health on Passenger Vessels, Which Governmental Agency Responds in the Event of a Biological Attack on a Vessel, and What Can Be Done to Prepare?
- I Saw it in a Movie: The Effectiveness of Health Regulations on International Travel
- Die a Hero or Live Long Enough to Become the Villain: Mass Casualty Preparedness in Hospitals and Protecting Doctors from Liability during Mass Casualty Events
- Review
- Public Policy Drivers during Global Public Health Emergencies: Focus on Ebola
Keywords for this article
vaccine regulations;
Health and Human Services;
select agent research regulations
Articles in the same Issue
- Frontmatter
- Articles
- The BWC Gray Area: Locating the Blurry Line of Defining Biological Weapons
- Eco-Terrorism: A Legal Update on the Laws Protecting Scientific Research from Extremist Activists
- Legal Framework Surrounding the Development of Vaccines for Select Agents: Do the Legal Incentives Outweigh the Legal Burdens?
- Preparing for Agroterror: How is the Texas Animal Health Commission Implementing Federal Food Security Regulations?
- No Safe Haven: How the Chasm between the Laws Governing Refugees and Mass Gatherings Has Contributed to Health Crises
- Lost at Sea – Plunge into Cruise Ship Jurisdiction: Which Governmental Agency Regulates Health on Passenger Vessels, Which Governmental Agency Responds in the Event of a Biological Attack on a Vessel, and What Can Be Done to Prepare?
- I Saw it in a Movie: The Effectiveness of Health Regulations on International Travel
- Die a Hero or Live Long Enough to Become the Villain: Mass Casualty Preparedness in Hospitals and Protecting Doctors from Liability during Mass Casualty Events
- Review
- Public Policy Drivers during Global Public Health Emergencies: Focus on Ebola
